Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
hyaluronan + thrombin
- Development stage
- Phase 3
- Lead developer
- BMIKorea
- Modality
- Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Topical
01
Overview
Hyaluronan + thrombin is a combination topical treatment evaluated by The University of Texas Medical Branch at Galveston for the acceleration of wound healing at skin graft donor sites in burn patients. The formulation combines hyaluronan (hyaluronic acid), a naturally occurring glycosaminoglycan that promotes cell migration and tissue repair, with thrombin, a key enzyme in the coagulation cascade. Thrombin facilitates hemostasis by converting fibrinogen into fibrin, while hyaluronan interacts with cellular receptors such as CD44 to stimulate re-epithelialization. This combination was studied in a Phase 2/3 clinical trial (NCT01113307) to compare its efficacy against standard treatments like Scarlet Red and microbial nanocellulose dressings.
- Other names
- hyaluronic acid and thrombin dressinghyaluronan/thrombin
02
Targets
CD44 (CD44 antigen)F2 (Thrombin)HMMR
Beyond the preview
Go deeper on hyaluronan + thrombin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on hyaluronan + thrombin.